← Evidence map

ReviewPharmacology research & perspectives2022

Molnupiravir: A new candidate for COVID-19 treatment.

Fariba Pourkarim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

64 papers cite itlatest 60 shown

2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34968008